Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 5/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5137857 | 0.93 | C5AR1 (0.52) | C5AR1OPRM1HDAC8MEN1KMT2A | |
| SCHEMBL6342639 | 0.92 | C5AR1 (0.56) | C5AR1OPRM1HDAC8MEN1KMT2A | |
| SCHEMBL6259390 | 0.92 | C5AR1 (0.56) | C5AR1OPRM1HDAC8MEN1KMT2A | |
| SCHEMBL5136056 | 0.92 | C5AR1 (0.56) | C5AR1OPRM1HDAC8MEN1KMT2A | |
| SCHEMBL5136178 | 0.92 | C5AR1 (0.51) | C5AR1OPRM1HDAC8MEN1KMT2A | |
| SCHEMBL5136870 | 0.91 | C5AR1 (0.54) | C5AR1OPRM1HDAC8MEN1KMT2A | |
| SCHEMBL5137894 | 0.89 | C5AR1 (0.49) | C5AR1OPRM1HDAC8MEN1KMT2A | |
| SCHEMBL6342543 | 0.88 | C5AR1 (0.56) | C5AR1OPRM1HDAC8MEN1KMT2A | |
| SCHEMBL5136013 | 0.88 | C5AR1 (0.56) | C5AR1OPRM1HDAC8MEN1KMT2A | |
| SCHEMBL5135005 | 0.88 | C5AR1 (0.52) | C5AR1OPRM1HDAC8MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6777422-B2 | FOR TREATING A VARIETY OF INFLAMMATORY AND IMMUNE SYSTEM DISORDERS | NEUROGEN CORP. | 2004-08-17 | — | — | US | claimed |
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| US-20050158663-A1 | Regenerative plate making and printing process, and plate making and printing apparatus | MITSUBISHI HEAVY INDUSTRIES, LTD. (JP) | 2005-07-21 | — | — | US | disclosed |
| US-6916830-B2 | Substituted tetrahydroisoquinolines as C5a receptor modulators | NEUROGEN CORPORATION (US) | 2005-07-12 | — | — | US | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| US-6777422-B2 | FOR TREATING A VARIETY OF INFLAMMATORY AND IMMUNE SYSTEM DISORDERS | NEUROGEN CORP. | 2004-08-17 | — | — | US | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |